Glioma initiating cells form a differentiation niche via the induction of extracellular matrices and integrin αV.
Ontology highlight
ABSTRACT: Glioma initiating cells (GICs) are considered responsible for the therapeutic resistance and recurrence of malignant glioma. To clarify the molecular mechanism of GIC maintenance/differentiation, we established GIC clones having the potential to differentiate into malignant gliomas, and subjected to DNA microarray/iTRAQ based integrated proteomics. 21,857 mRNAs and 8,471 proteins were identified and integrated into a gene/protein expression analysis chart. Gene Ontology analysis revealed that the expression of cell adhesion molecules, including integrin subfamilies, such as α2 and αV, and extracellular matrices (ECMs), such as collagen IV (COL4), laminin α2 (LAMA2), and fibronectin 1 (FN), was significantly upregulated during serum-induced GIC differentiation. This differentiation process,
SUBMITTER: Niibori-Nambu A
PROVIDER: S-EPMC3660593 | biostudies-literature | 2013
REPOSITORIES: biostudies-literature
ACCESS DATA